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Background: The finding of unexpandable lung (UL) at an early timepoint is of increasing importance 
in guiding treatment decisions in patients with malignant pleural effusion (MPE). Pleural manometry is the 
most common technique to delineate UL, however it has never been measured via an indwelling pleural 
catheter (IPC). To further the evidence base we analysed all patients in the IPC-PLUS study who had 
manometry performed during IPC insertion for the ability to predict substantial UL using manometry.
Methods: All patients enrolled in IPC-PLUS who had manometry performed at IPC insertion and 
radiographic assessment of UL at day 10 were included. Elastance curves were visually inspected for each 
patient. Initial pleural pressure, closing pleural pressure, and terminal elastance were analysed for their 
differences and predictive ability in those with substantial UL, defined as ≥25% entrapment on chest 
radiography.
Results: A total of 89 patients had manometry performed at IPC insertion with subsequent radiographic 
assessment of UL and interpretable elastance curves. Those with substantial UL had a significantly lower 
median closing pleural pressure (−15.00 vs. 0.00 cmH2O, P=0.012) and higher terminal elastance (12.03 vs. 
8.59 cmH2O/L, P=0.021) compared to a combined group with no or partial UL. However, the predictive 
ability of these factors to discriminate substantial UL was poor, with areas under the receiver operating 
characteristic curves of 0.695 and 0.680 for closing pleural pressure and elastance respectively.
Conclusions: Our results suggest that manometry is not useful in accurately predicting substantial UL 
when used via an IPC at the time of insertion.
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Introduction
Malignant pleural effusion (MPE) affects at least 150,000 
patients per year in the US alone (1), often recurring after 
drainage and leading to debilitating dyspnoea. The finding 
of substantial unexpandable lung (UL) at an early timepoint 
in these patients is of increasing importance in guiding 
treatment decisions. Traditionally, those with adequate 
pleural apposition are eligible for inpatient talc pleurodesis 
(2,3) whilst those with UL, also sometimes referred to as 
‘trapped’, ‘entrapped’ or ‘non-expansile’ lung, underwent 
repeated drainage and/or ambulatory management using 
an indwelling pleural catheter (IPC) (4). IPCs, however, are 
increasingly inserted first line in response to patient choice, 
even in those without evidence of UL (5,6). The recent 
IPC-Plus trial, which examined the use of outpatient talc 
pleurodesis via an IPC for MPE, showed this combination 
approach achieved better pleurodesis than IPC alone in 
those without substantial UL (7).
U L ,  a n d  i t s  s e v e r i t y,  m a y  b e  s u g g e s t e d  b y 
hydropneumothorax or a persistent fluid collection on chest 
radiography following effusion drainage, with patients also 
potentially experiencing excessive cough or central chest 
pain during aspiration. These findings, however, may not 
become apparent until after definitive treatment begins. 
Real-time pleural manometry during thoracentesis has 
been advocated as a method of identifying UL earlier (8). 
However, pulmonologists continue to disagree over its clinical 
utility (9), sensitivity (10,11) and the specific manometry values 
which delineate between ‘normal’ and UL (10-12).
As part of the IPC-Plus study, pleural manometry was 
performed during IPC insertion in a proportion of patients 
as part of a pre-planned exploratory sub-study, and we 
report the results here (13). The aims of the sub-study were 
twofold: firstly, to assess the utility of manometry measured 
via IPC at the time of insertion to predict substantial UL, 
which could help guide patient management in the future, 
specifically with regards to later talc instillation; and 
secondly to add further evidence to clarify the efficacy of 
pleural manometry more generally.
Methods
Trial participants
Patients were eligible for the main IPC-Plus study if they 
had a symptomatic MPE which was suitable for treatment 
with an IPC, had an expected survival of 2 months or more, 
and an Eastern Cooperative Oncology Group performance 
status of 3 or better. Patients with known pre-existent 
UL were excluded from trial entry (7). Ethics approval 
for recruitment was obtained from the South Central 
(Oxford A) Research Ethics Committee (approval number: 
12/SC/0242).
UL categorisation
IPCs were inserted using standard technique with 
patients supine. After 10 days of ambulatory drainage, 
chest  radiography was performed to evaluate the 
presence and degree of UL and subsequent suitability for 
r andomiza t ion  (13 ) .  Per s i s t ing  f lu id  co l l ec t ion 
despi te  ambulatory  dra inage and/or  ev idence of 
hydropneumothorax were felt to represent underlying UL. 
Those with an estimated degree of UL exceeding 25% of 
the hemithorax (i.e., less than 75% pleural apposition) were 
excluded from further participation in the main trial.
For the purpose of the analysis described here, 
radiographic degree of UL at day 10 was assessed by two 
independent clinicians and was considered the diagnostic 
standard. Patients were divided into three groups: (I) those 
with no discernible UL (No-UL); (II) those with partial 
UL (P-UL, affecting <25% of the hemithorax); and (III) 
those with substantial UL (S-UL, affecting ≥25% of the 
hemithorax).
Use of manometry via IPCs
The measurement of pleural pressure at insertion, via 
the IPC drainage circuit, was recommended in the study 
protocol, but was ultimately left at the discretion of the 
local investigator. Pleural pressure was assessed using a 
commercially-available, single-use digital manometer 
(Mirador Biomedical)  (14).  Operators fol lowed a 
standardised operating procedure (see online supplement: 
http://fp.amegroups.cn/cms/68c570d3db37deab671bc3
7f9b2b6445/jtd.2020.02.25-1.pdf) and were instructed 
to sit the patient up post-IPC insertion to perform 
manometry, to increase the chances of the drain sitting in 
the dependent portion of fluid. Measurements were taken 
at the level of the IPC entering the pleural cavity and end-
expiratory pressures were recorded. As movement during 
measurement can cause false readings the pressure recorded 
at each volume required consistency by obtaining the same 
value over a minimum of four patient breaths. An end-
expiratory reading was taken immediately after insertion, 
before any fluid removal, and this was recorded as the 
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initial pleural pressure. Operators were given the option 
to record subsequent readings after every 100 or 200 mL 
of fluid removed. The total volume drained immediately 
after insertion was left at the discretion of the operator. As 
many patients weren’t drained to ‘dryness’ during catheter 
insertion, the final pressure measurement did not necessarily 
reflect the pressure of the fully drained hemithorax.
To avoid lung deformation forces potentially affecting 
final pleural pressure measurements, the ‘closing pleural 
pressure’ was documented as the last pressure recorded 
with subsequent drainage of at least 30 mL. Operators were 
advised to consider terminating aspiration in the event of 
significant chest pain or cough; an end-expiratory pleural 
pressure reading of −20 cmH2O or lower; or if no further 
drainage could be achieved.
Pleural pressure and manometry graph analysis
Manometry recordings were used to generate graphs of 
pressure against volume (elastance curves, Figure 1) for 
each patient. These elastance curves were assessed and 
categorized by two pulmonologists who remained blind 
to all clinical data and previous radiographic assessments 
of UL. Using previously-described parameters (15), each 
graph was assigned to one of the following groups, which 
aimed to further characterise the nature of the UL (if 
present): a shallow monophasic curve (representing no 
discernible UL); a steep monophasic curve (representing 
a largely fixed, ‘trapped lung’); or a biphasic curve 
(representing ‘lung entrapment’ with some initial capacity 
for lung expansion). For biphasic curves, both assessors 
agreed upon an inflection point. To quantify elastance, 
curves were divided into up to three distinct portions using 
a previously described method (12). Terminal elastance was 
calculated using linear regression of monophasic curves, 
or the section following the inflection point for biphasic 
curves. If curves had fewer than 4 manometric readings or 
if both blinded assessors couldn’t discern any consistent 
pattern to allow analysis, then these results were excluded 
from further analysis.
Statistical methods
All statistical tests were performed using IBM SPSS Statistics 
Version 23 (Armonk, NY, USA). Differences in initial pleural 
pressure, closing pleural pressure and terminal elastance were 
compared between the radiographic groups described above. 
Additionally, for consistency with the original trial’s methods 
and to reflect clinical relevance, the radiographic categories 
where talc pleurodesis was not contraindicated (No-UL and 
P-UL) were combined to form a separate group (No+P-UL) 
for comparison against categories in which talc pleurodesis 
was contraindicated (S-UL).
Descriptive statistics were performed to evaluate baseline 
differences between participants undergoing manometry. 
The Chi-squared test was used for categorical variables 
and Mann Whitney U test for continuous variables. For 
comparisons between independent radiographic groups 
the Jonckheere-Terpstra Test for ordered alternatives was 
used, and for two-group comparisons Mann-Whitney U 
tests were used. An α value of 0.05 was taken as statistically 
significant.
Factors demonstrating significance between the 
combined group of No+P-UL compared to S-UL were 
assessed for ability to predict substantial lung entrapment 
using receiver operating characteristic (ROC) curves. Cut-
off values were extracted using a combination of Youden’s 
index and visual inspection of the ROC curve. We also 
used our dataset to attempt to validate previously-reported 
elastance values used to delineate UL (10-12).
Results
Of the 250 patients enrolled into IPC-Plus (7), 113/250 
(45%) at 13/18 recruitment centres had manometry 
performed. Baseline characteristics between those having 
and not having manometry performed at IPC insertion 
are shown in Table 1. Patients undergoing manometry had 
Figure 1 An example of the pleural pressure/volume (elastance) 
curves generated for a patient without unexpandable lung (green) 
and another with unexpandable lung (blue).
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a greater median amount of fluid removed during their 
initial drainage (1.11 L, IQR 0.90–1.34 L vs. 1.00 L, IQR 
0.75–1.40 L, P=0.018), but no other significant baseline 
differences were observed.
Eight patients were excluded having withdrawn from the 
study prior to day 10 assessment, meaning 105/250 (42%) 
were assessed radiographically for UL. Following visual 
inspection of manometry curves, 16 patients were deemed 
to have uninterpretable data, leaving 89/250 (36%) (Figure 
2).
Initial pleural pressure to assess UL
There was no difference in median initial pleural 
pressure  between any  of  the  three  radiographic 
g r o u p s  w h e n  c o m p a r e d  i n d i v i d u a l l y  ( N o - U L 
=5 .50  cmH 2O,  IQR 0 .00–+12 .25  cmH 2O,  P-UL 
=4.00 cmH 2O, IQR −2.00–+16.00 cmH 2O,  S-UL 
=2.00 cmH2O, IQR −1.50–+8.50 cmH2O, P=0.288), or 
when the No-UL and P-UL groups were combined 
and compared to S-UL (No+P-UL =5.00 cmH2O, IQR 
0.00–+13.00 cmH2O, S-UL =2.00 cmH2O, IQR −1.50– 
+8.50 cmH2O, P=0.267).
Closing pleural pressure to assess UL
There were significant differences in median closing 
pleural pressures between the three radiographic groups 
(No-UL =0.00 cmH2O, IQR −12.5–+6.50 cmH2O, P-UL 
=−10.00 cmH2O, IQR −21.00–+9.00 cmH2O, S-UL 
=−15.00 cmH2O, IQR −27.00–−1.00 cmH2O, P=0.010, 
Table 2). On pairwise comparisons, this difference occurred 
between the groups No-UL and S-UL (P=0.012). A 
significant difference persisted when comparing the 
combined No-UL+P-UL group to S-UL (No+P-
UL =0.00 cmH2O, IQR −14.75–+6.75 cmH2O, S-UL 
=−15.00 cmH2O, IQR −27.00–−1.00 cmH2O, P=0.012, 
Figure 3).
The ability of closing pleural pressure to predict 
radiographic S-UL as opposed to the combined No+P-
UL group was assessed. The ROC curve generated an area 
under the curve (AUC) of 0.695 and a closing pressure of 
−20.5 cmH2O was extrapolated to predict UL (see Table 
3 and Figure 4). This value identified 6/17 (35%) of those 
with S-UL with five false positive results, giving a positive 
predictive value of 6/11 (55%). It correctly identified 67/72 
(93%) patients without S-UL.
250 enrolled in IPC-Plus trial
Excluded
137 without Manometry
113 patients had manometry 
performed during IPC 
insertion
Excluded
8 without Day 10 Chest 
Radiograph to assess UL
105 with Manometry & Day 
10 Chest Radiograph
Excluded
16 – Uninterpretable graphs 
(13 No UL, 2 Partial UL, 3 
Substantial UL)
57 No UL 15 Partial UL 17 Substantial UL
Figure 2 Flow diagram of categorisation of patients into individual manometric groups. UL, unexpandable lung; IPC, indwelling pleural 
catheter.
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Terminal elastance to assess UL
Terminal elastance and closing pleural pressure were 
significantly correlated (Pearson correlation −0.650, 
P<0.001). When using terminal elastance to predict 
radiographic UL, there were significant differences 
between the 3 groups (No-UL =8.00 cmH2O/L, IQR 4.76– 
11.79 cmH2O/L, P-UL =9.00 cmH2O/L, IQR 6.25– 
15.22 cmH2O/L, S-UL =12.03 cmH2O/L, IQR 7.42– 
34.5 cmH2O/L, P=0.022). Pairwise comparisons showed this 
occurred between the groups No-UL and S-UL (P=0.027). 
Comparing the combined No+P-UL group with the S-UL 
group also yielded a significant difference (No+P-UL 
=8.59 cmH2O/L, IQR 5.54–12.12 cmH2O/L, S-UL 
=12.03 cmH2O/L, IQR 7.42–34.5 cmH2O/L, P=0.021, Table 2).
When assessing the ability of elastance to predict S-UL 
the ROC curve generated an AUC of 0.680 (Figure 4). 
Using an extrapolated value of 27.3 cmH2O/L to predict 
UL, 5/17 (29.4%) cases were correctly predicted, with four 
false positive results, giving a positive predictive value of 
5/9 (56%). And, 68/72 (94%) patients without S-UL were 
correctly predicted using this cut-off (Table 3).
Discussion
To our knowledge, this is the first study to describe the 
assessment of pleural pressure measured via an IPC at the 
time of insertion. We aimed to assess the feasibility of this 
technique and, being one of the largest published datasets 
on pleural manometry, also further the knowledge base in 
this area. Whilst we do not necessarily envisage manometry 
results collected via an IPC to be different to conventional 
methods, it is important to note this technique has not been 
validated or compared with usual methods.
As a result of the IPC-Plus study, early outpatient 
administration of talc through an IPC is likely to become 
increasingly common (7). In this setting, pre-emptive 
identification of substantial UL could potentially avoid both 
the inconvenience of the additional hospital visit needed 
to perform radiography, as well as the potential discomfort 
associated with talc instillation, which is less likely to be 
successful.
Elastance is the commonest measurement used to infer 
the presence of UL (10-12). Our results show a significant 
difference in elastance between those with substantial UL 
and those with no or partial (<25%) UL (P=0.021). Whilst 
radiological definitions of UL often differ, our results are 
broadly consistent with other studies reporting higher 
elastance in those with UL (11,16). We also found no 
difference in the initial pleural pressure between any groups 
tested, a result previously described elsewhere (16).
In general, the use of closing pleural pressure in 
predicting UL is less commonly reported in the literature, 
Table 2 Manometry values in individual radiographically defined groups of unexpandable lung severity. No+P-UL represents a combined group 
of No-UL plus P-UL
Measurement No-UL P-UL No+P-UL S-UL Significant difference 
Initial pleural pressure 
(median & IQR) (cmH2O)
5.50  
(0.00–+12.25)
4.00  
(−2.00–+16.00)
5.00  
(0.00–+13.00)
2.00  
(−1.50–+8.50)
3 groups* P=0.288,  
2 groups** P=0.267
Closing pleural pressure 
(median & IQR) (cmH2O)
0.00  
(−12.5–+6.50)
−10.00  
(−21.00–+9.00)
0.00  
(−14.75–+6.75)
−15.0  
(−27.00–−1.00)
3 groups* P=0.010,  
2 groups** P=0.012
Terminal elastance (median 
& IQR) (cmH2O/L)
8.00  
(4.76–11.79)
9.00  
(6.25–15.22)
8.59  
(5.54–12.12)
12.03  
(7.42–34.5)
3 groups* P=0.022,  
2 groups** P=0.021
*, comparison between groups No-UL, P-UL and S-UL; **, comparison between groups No+P-UL and S-UL. IQR, interquartile range.
Figure 3 Differences in closing pleural pressure between different 
radiographically-defined groups of unexpandable lung severity. 
UL, unexpandable lung. 
C
lo
si
ng
 P
le
ur
al
 P
re
ss
ur
e 
(c
m
H
2O
)
P=0.012
P=0.012
No UL Partial UL
Radiographical assessment of Unexpandable Lung
Substantial UL
50
25
0
−25
−50
−75
1380 Halford et al. Manometry via IPC to predict UL
© Journal of Thoracic Disease. All rights reserved. J Thorac Dis 2020;12(4):1374-1384 | http://dx.doi.org/10.21037/jtd.2020.02.25
despite previously being used to facilitate safe drainage 
during thoracentesis (17). We found significant differences 
between the radiographic groups No-UL and S-UL in the 
median closing pleural pressure. This effect persisted when 
comparisons were made between those with S-UL and a 
combined group of patients with No-UL or P-UL. Our 
finding supports work from a previously-reported small 
series where a trend for significance was found whereby 
those with UL had lower closing pleural pressures (16).
We noted similar predictive abilities of closing pleural 
pressure and elastance in delineating substantial UL, 
yielding areas under the ROC curve of 0.695 and 0.680 
respectively, with the latter result similar to another study 
in which elastance had an area under the ROC curve of 0.69 
for predicting UL in 34 patients (10). However, closing 
pressure may actually be a more attractive predictor of UL 
than elastance in clinical practice, with the latter requiring 
multiple measurements to be taken and charted.
Additionally, our extrapolated closing pleural pressure 
cut-off value of −20.5 cmH2O is similar to the recommended 
value of −20.0 cmH2O commonly used to guide termination 
of therapeutic aspiration due to unsafe pleural pressures (17). 
The 6/11 (55%) patients who had a closing pleural pressure 
<−20 cmH2O had substantial UL, implying that if pressures 
are being monitored at thoracentesis to facilitate safe 
drainage, a value of −20 cmH2O may identify an unsafe 
drainage pressure, possibly due to the increased likelihood 
of underlying UL. However, recently published work has 
shown that the patient-derived benefit of using manometry 
to facilitate safe drainage is limited, which may lead to its 
decreasing use for this indication (18).
In general, however, the predictive ability of both 
elastance and closing pleural  pressure was poor. 
Whilst specificity was 94% and 93% for an elastance 
>27.3 cmH2O/L and closing pressure <−20.5 cmH2O 
respectively, sensitivity at these values was 29% and 35%. 
Likewise, when using our series to validate traditional 
manometric cut-offs reported in the literature (10-12), 
we observed similar results with a sensitivity of 35% for 
an elastance of >19 cmH2O/L to predict UL (Table 3). 
This is similar to findings of a 40% sensitivity for an 
elastance of >19 cmH2O/L to predict radiographical UL 
previously reported elsewhere (10), suggesting that some 
patients with substantial UL have ‘normal’ elastance (12). 
However, this is not consistently seen in the literature (11), 
perhaps due to differing diagnostic criteria for substantial 
UL. Some authors previously classified UL as post-
Table 3 Ability of different manometry values to predict substantial unexpandable lung on subsequent chest radiography
Method to predict 
unexpandable lung
Area under the 
receiver operating 
characteristic curve 
Sensitivity (95% CI) Specificity (95% CI)
Positive predictive  
value (95% CI)
Negative predictive  
value (95% CI)
Closing pleural pressure 
<−20.5 cmH2O
0.695 0.35 (0.14–0.62) 0.93 (0.85–0.98) 0.55 (0.23–0.83) 0.86 (0.76–0.93)
Terminal Elastance 
>27.3 cmH2O/L
0.680 0.29 (0.10–0.56) 0.94 (0.86–0.99) 0.56 (0.21–0.86) 0.85 (0.75–0.92)
Terminal Elastance 
>19.0 cmH2O/L
0.680 0.35 (0.14–0.62) 0.86 (0.76–0.93) 0.38 (0.15–0.65) 0.85 (0.75–0.92)
Terminal Elastance 
>14.5 cmH2O/L
0.680 0.41 (0.18–0.67) 0.80 (0.70–0.89) 0.33 (0.15–0.57) 0.85 (0.75–0.93)
CI, confidence interval.
Figure 4 Receiver operating characteristic curve for the ability 
of closing pleural pressure and terminal elastance to predict 
substantial unexpandable lung.
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thoracentesis pneumothorax in ‘most places’ of the 
hemithorax (11), whereas others only required post-
thoracentesis pneumothorax confined to the lower lobe (10). 
As manometry is a reflection of pleural pressure in the 
whole hemithorax, if diagnosis is based on a segment of the 
hemithorax only, the drastic pressure changes associated 
with unexpandable areas are likely to be dampened by the 
less pronounced changes in normal areas of expansion (10). 
Different definitions of UL, therefore, are likely to affect 
the predictive ability of manometry. Our definition of 
substantial UL is different from other studies, which may 
reflect why we observed a better predictive value with a 
different elastance cut-off value (27.3 cmH2O/L) than those 
traditionally used. However, overall, neither the cut-off 
values of elastance or closing pleural pressure extrapolated 
from our results, nor the traditionally used elastance values, 
had particularly good predictive properties using our 
dataset, limiting their clinical utility.
Major strengths of this study include its large sample 
size compared to previous publications (10,11,16), and the 
pragmatic populations of patients and investigators taking 
measurements. The latter is of particular interest since a 
commonly perceived barrier to widespread manometry use 
has been its applicability outside of specialist centres. We 
also used radiographically-defined UL as our comparator, 
something not consistently performed in studies reporting 
manometry (19,20). Additionally, radiographs were taken 
after a period of regular drainage, reducing the likelihood 
that UL would be obscured by residual fluid. On average 
patients had over 4 litres drained prior to radiographic 
assessment, whereas other studies often assess for UL 
following a single drainage of approximately 1 litre (21,22).
There are some limitations to this study, primarily 
arising because these data comprise an exploratory subset 
analysis from another study. As not all patients enrolled 
in the parent study had manometry performed at IPC 
insertion this may have introduced a degree of selection 
bias, although we feel it unlikely that this will have had a 
significant effect on our results. Firstly, known significant 
UL based on prior radiology was an exclusion criterion for 
enrolment. Furthermore, there are limited useful predictors 
of UL prior to drainage, and as Table 1 highlights patients 
having manometry performed had similar characteristics to 
those that did not.
We used a single-use digital manometer to measure 
pleural pressures, whilst more sophisticated methods are 
available, such as electronic manometers (14), this was not 
felt to be practical in a multi-centred study nor reflective 
of what could be achieved in clinical practice outside of a 
few specialist sites. In fact, digital manometers have been 
shown to correlate well with these more sophisticated 
techniques (14). However their use via an IPC has not been 
validated, with this approach technically more complex 
than during standard thoracentesis. Additionally, due to 
the pragmatic nature of the IPC-Plus study, it is likely that 
operators in our study had less experience in manometry 
when compared to those with research interests in this area 
or for whom manometry is a routine technique.
As initial drainage using manometry was not continued to 
‘dryness’, and residual fluid remaining after initial drainage 
was not quantified, this may underestimate the number with 
UL predicted by manometry. This is an inherent limitation 
of our methodology as our aim was to facilitate safe 
regular ambulatory drainage with a view to then undergo 
pleurodesis rather than undertake large-volume drainage 
at insertion. However, to our knowledge, only one study 
has attempted full drainage whilst assessing for residual 
fluid, using manometry to facilitate safe large-volume 
drainage as opposed to diagnose UL (18). During this study, 
whilst attempting maximal drainage, on average patients 
had 1.1 litres removed prior to spontaneous cessation of 
fluid or patients met criteria for discontinuation, mostly 
due to symptoms limiting further drainage, despite many 
having evidence of residual effusion (18). These volumes 
are similar to the volumes removed during initial drainage 
post-IPC insertion in our study and highlights that in many 
patients complete fluid evacuation during initial drainage 
is unachievable. Furthermore, the volumes removed on 
initial drainage with manometry measurements in our study 
compare favourably with those in previous thoracentesis-
based manometry studies, and therefore should be 
comparable (10-12). Whilst patients had different amounts of 
fluid removed, rather than selecting a specific drainage volume 
for analysis, we opted to maximise our available data, as earlier 
cessation would potentially underestimate UL by being unable 
to identify those with a ‘late’ inflection point on a biphasic 
elastance curve. Unfortunately, due to the exploratory nature 
of this study we do not have information on the reasons for 
terminating drainage in patients.
Radiographic UL was assessed at day 10 post-insertion 
and compared to manometry performed 10 days prior. 
Theoretically patients with manometry indicative of UL 
may have subsequent expansion and thus not classified 
radiographically as substantial UL by day 10. This would 
explain the false positive manometry results observed in 
our cohort in which later radiographic assessment of UL 
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was undertaken compared to previous studies in which 
radiographs were performed sooner after manometry, and 
therefore false positive manometry results may not have 
been observed (11,12). Likewise, patients with UL assessed 
at day 10 may have subsequent expansion with further 
drainage if followed up. However, whilst immediate post-
insertion imaging was not available, due to air entrainment 
during insertion these images can incorrectly suggest UL. 
Furthermore, clinicians contemplating using talc via an IPC 
to manage MPE need an acceptable timepoint, balancing 
the requirement of adequate drainage allowing pleural 
apposition to facilitate effective talc pleurodesis, whilst 
minimising delay to intervention in this palliative cohort. 
Day 10, as used in IPC-Plus (7), is now a proven timepoint 
to assess UL and perform pleurodesis. In considering this, 
we felt it was an acceptable compromise between allowing 
regular, but not aggressive, drainage to facilitate full chest 
evacuation, with patients having approximately 4 litres on 
average drained between insertion and day 10 imaging. 
This avoids categorising slow-to-expand lungs, which may 
benefit from pleurodesis when adequately drained, as true 
UL, whilst also minimising significant delay to definitive 
pleurodesis. Previous studies which compare manometry 
with immediate post-drainage imaging may fail to delineate 
slow-to-expand and true UL (11,12). Therefore, we feel the 
correlation between manometry at initial drainage and UL 
at day 10 is still of vital importance.
Chest radiography was used as our comparator to 
assess lung expansion. We acknowledge that UL may be 
difficult to define on chest radiography, with its inability 
to demonstrate pathology in three dimensions being 
particularly relevant and may lead to UL underestimation. 
These reasons may cause the poor inter-observer correlation 
seen when assessing radiographs for UL (23) and the varied 
rates of UL post-drainage in previous studies, which often 
use different diagnostic criteria of UL (24,25). Whilst more 
sophisticated techniques exist to assess UL, for example 
interval CT scanning (26), this was felt to be neither 
practical nor reflective of what occurs in clinical practice for 
use in our current study. Furthermore most other studies 
have compared manometry with chest radiography, hence 
our study should be comparable to those (11,12,16). In fact 
our study suggested higher rates of UL compared to those 
previous studies using single-thoracentesis, which may 
reflect our methodology of assessing radiographs after 10 
days of ambulatory drainage, with prolonged fluid removal 
allowing better characterisation of UL.
Unfortunately, our sub-study was not powered to find 
a difference in pleurodesis success rate between those with 
full expansion versus partial UL in this manometric cohort. 
However this studies parent trial showed that the efficacy 
of pleurodesis was not impacted by the presence of a small 
degree of UL, defined using the same criteria for partial UL as 
used here, compared to those deemed to have fully expansile 
lungs, suggesting full lung expansion is not a prerequisite to 
effective pleurodesis in the context of an IPC (7).
Although in this study we analysed terminal elastance, 
previous studies often fail to specify how elastance is 
calculated from biphasic curves; meaning our results may 
not be directly comparable where unspecified calculation 
techniques were used. However, there is growing consensus 
that biphasic curves represent 2 processes, with terminal 
elastance more likely to reflect the point of abnormal 
pleural pathology, and hence be of more importance when 
interpreting elastance curves (9,27).
Conclusions
This exploratory analysis, whilst showing significant 
differences in closing pleural pressure and terminal 
elastance in those with substantial UL, suggests that the 
predictive properties of manometry to detect UL are poorer 
than previously suggested. Based on these results, we cannot 
recommend the use of manometry at the time of IPC 
insertion to accurately predict those with substantial UL 
and guide the use of outpatient talc pleurodesis. However, 
there may be a role for closing pleural pressure, if used to 
facilitate safe drainage, in predicting patients who may have 
UL if unsafe pleural pressures are reached during drainage.
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